NEW THERAPEUTIC AGENTS

A compound of formula I: or a compound of formula II: or pharmaceutically acceptable salts thereof, wherein R 1 -R 7 and X are as defined in the description, and the use of these compounds in therapy, in particular in treating cancer or as an inhibitor of the interaction of the MDM2 protein with p53...

Full description

Saved in:
Bibliographic Details
Main Authors HARDCASTLE IAN, ROBERT, GRIFFIN ROGER JOHN, GOLDING BERNARD, THOMAS, RIEDINGER CHRISTIANE, VALEUR ERIC, WATSON ANNA, FRANCES, NOBLE MARTIN
Format Patent
LanguageEnglish
French
German
Published 04.05.2011
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract A compound of formula I: or a compound of formula II: or pharmaceutically acceptable salts thereof, wherein R 1 -R 7 and X are as defined in the description, and the use of these compounds in therapy, in particular in treating cancer or as an inhibitor of the interaction of the MDM2 protein with p53.
AbstractList A compound of formula I: or a compound of formula II: or pharmaceutically acceptable salts thereof, wherein R 1 -R 7 and X are as defined in the description, and the use of these compounds in therapy, in particular in treating cancer or as an inhibitor of the interaction of the MDM2 protein with p53.
Author GRIFFIN ROGER JOHN
HARDCASTLE IAN, ROBERT
RIEDINGER CHRISTIANE
VALEUR ERIC
WATSON ANNA, FRANCES
NOBLE MARTIN
GOLDING BERNARD, THOMAS
Author_xml – fullname: HARDCASTLE IAN, ROBERT
– fullname: GRIFFIN ROGER JOHN
– fullname: GOLDING BERNARD, THOMAS
– fullname: RIEDINGER CHRISTIANE
– fullname: VALEUR ERIC
– fullname: WATSON ANNA, FRANCES
– fullname: NOBLE MARTIN
BookMark eNrjYmDJy89L5WQQ83MNVwjxcA1yDHANDfF0VnB0d_ULCeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAUbGhqbmJpaORsZEKAEAQrsgjQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate NEUE THERAPEUTISCHE MITTEL
NOUVEAUX AGENTS THÉRAPEUTIQUES
ExternalDocumentID EP2315749A2
GroupedDBID EVB
ID FETCH-epo_espacenet_EP2315749A23
IEDL.DBID EVB
IngestDate Fri Jul 19 15:59:43 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP2315749A23
Notes Application Number: EP20090769576
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110504&DB=EPODOC&CC=EP&NR=2315749A2
ParticipantIDs epo_espacenet_EP2315749A2
PublicationCentury 2000
PublicationDate 20110504
PublicationDateYYYYMMDD 2011-05-04
PublicationDate_xml – month: 05
  year: 2011
  text: 20110504
  day: 04
PublicationDecade 2010
PublicationYear 2011
RelatedCompanies CANCER RESEARCH TECHNOLOGY LIMITED
RelatedCompanies_xml – name: CANCER RESEARCH TECHNOLOGY LIMITED
Score 2.8122754
Snippet A compound of formula I: or a compound of formula II: or pharmaceutically acceptable salts thereof, wherein R 1 -R 7 and X are as defined in the description,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title NEW THERAPEUTIC AGENTS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110504&DB=EPODOC&locale=&CC=EP&NR=2315749A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT8Iw8ELQKG-KEvErezB7W0Ro6fawmNF1ThPGgkN5I2zrEl6AyIh_32tl6Iu-XdrkepfmPtu7A7ijqiGMI7sWhsoYoDhzpga5O5ZkfZkyJgubqALnYdQPJ-RlSqc1WFS1MLpP6KdujogSlaG8l1pfr3-SWL7-W7m5Txe4tHoMEtc38yrd16F46f7AFfHIH3GTc4TMaOyiG0MZcTzU1gfKi1Zt9sXbQBWlrH9blOAEDmNEtixPoSaXTTjm1eC1JhwNd-_dCO5Eb3MGrUi8G0koxl4sJskzN7wnESWv52AEIuGhhQfM9szMRLwnpdeCOsb48gIMila9oE7O5mmXFDK1kcQis2VmF5L08oc2tP9Ec_nP3hU0vpOg1OqQa6iXH1t5g1a0TG81_1_UWnME
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4QNOJNUSL46sH01oiwy7aHxpTt1qK0NFiUW0PbbcIFidT4951Wil70ttlNZl-Zxze7MwNwQ4uEMIbsaQiVEaAYC1YUcjc0yQYyZkxmOikCnD1_4M7I45zOa7CsYmHKPKGfZXJE5KgE-T0v5fX6x4lll38rN7fxErve7p3QtNW0cvd1KV66PTRFMLEnXOUcW6o_NdGMoYwYFkrrPYaIsEizL16GRVDK-rdGcY5gP0Biq_wYanLVhAavCq814cDbvndjc8t6mxNo-eJVCV0xtQIxC0dcsR6EHz6fguKIkLsaThDtNhOJYLeUfgvqiPHlGSgUtXpGjZQt4h7JZKyjoZ8lukz0TJJ-eteG9p9kOv-MXUPDDb1xNB75T-dw-O0QpVqXXEA9f_-Ql6hR8_iqPIsvWvd17w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NEW+THERAPEUTIC+AGENTS&rft.inventor=HARDCASTLE+IAN%2C+ROBERT&rft.inventor=GRIFFIN+ROGER+JOHN&rft.inventor=GOLDING+BERNARD%2C+THOMAS&rft.inventor=RIEDINGER+CHRISTIANE&rft.inventor=VALEUR+ERIC&rft.inventor=WATSON+ANNA%2C+FRANCES&rft.inventor=NOBLE+MARTIN&rft.date=2011-05-04&rft.externalDBID=A2&rft.externalDocID=EP2315749A2